Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia

BACKGROUND: Cambodia is the epicentre of the emergence of Plasmodium falciparum drug resistance. Much less is known regarding the drug susceptibility of the co-endemic Plasmodium vivax. Only in vitro drug assays can determine the parasite’s intrinsic susceptibility, but these are challenging to impl...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesch, Camille, Mairet-Khedim, Mélissa, Kim, Saorin, Lek, Dysoley, Popovici, Jean, Witkowski, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303819/
https://www.ncbi.nlm.nih.gov/pubmed/32211790
http://dx.doi.org/10.1093/jac/dkaa092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303819/
https://www.ncbi.nlm.nih.gov/pubmed/32211790
http://dx.doi.org/10.1093/jac/dkaa092

Ejemplares similares